Form 8-K - Current report:
SEC Accession No. 0001213900-19-018619
Filing Date
2019-09-23
Accepted
2019-09-23 09:42:08
Documents
4
Period of Report
2019-09-18
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT f8k091819_neuroonemedical.htm 8-K 18399
2 AMENDMENT TO EXCLUSIVE START-UP COMPANY LICENSE AGREEMENT BY AND BETWEEN WISCONS f8k091819ex10-1_neuroone.htm EX-10.1 9260
3 PRESS RELEASE DATED SEPTEMBER 23, 2019 ANNOUNCING COMPANY'S FIRST SALE OF SEEG D f8k091819ex99-1_neuroone.htm EX-99.1 8152
4 GRAPHIC ex10-1_001.jpg GRAPHIC 3112
  Complete submission text file 0001213900-19-018619.txt   41563
Mailing Address 10901 RED CIRCLE DR. SUITE 150 MINNETONKA MN 55343
Business Address 10901 RED CIRCLE DR. SUITE 150 MINNETONKA MN 55343 (952) 426-1383
NEUROONE MEDICAL TECHNOLOGIES Corp (Filer) CIK: 0001500198 (see all company filings)

EIN.: 270863354 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 000-54716 | Film No.: 191106398
SIC: 3841 Surgical & Medical Instruments & Apparatus